- Home
- Services
- saudi arabia
- tissue biopsy
Show results for
Refine by
Tissue Biopsy Services Available In Saudi Arabia
6 services found
by:Avaden Biosciences, Inc. based inSeattle, WASHINGTON (USA)
Over 350 clinical data points per patient. Over 7,500 consented surgeries per month for custom tissue. Over 10,000 consented patients in ambulatory setting for blood draws. Fresh, FFPE, or frozen custom protocols - paired tissue/blood. 24 Hour guaranteed delivery to North America and Europe. Complete customization of patient inclusion / exclusion parameters. Single time point or patient ...
Manufactured by:Bionano based inSan Diego, CALIFORNIA (USA)
Submit your samples to Bionano Data Services and receive an appropriately filtered set of structural variant calls. SV data is presented using the Bionano Access® visualization software. Files can be exported in the format of your choice. The Bionano Support team will work with you on experiment design and analysis training. Full analysis is available as an ...
by:Lucence Health Inc. based inPalo Alto, CALIFORNIA (USA)
By requiring only a single blood sample, LiquidHALLMARK provides important information for cancer care especially when tissue by invasive biopsy is insufficient or ...
Manufactured by:Cysview, Trademark of Photocure based inPrinceton, NEW JERSEY (USA)
A cystoscopy is a medical procedure where a urology healthcare professional uses a thin, tube-like telescope called a cystoscope to look directly into the bladder for a close examination of the lining. This procedure is used to help find the cause of symptoms and to treat or monitor ...
Manufactured by:IMB Dx, Inc. based inSeoul, SOUTH KOREA
Analysis of cancer-related genes through blood. Through a simple blood draw, key genes related to various cancer types of solid cancers (including gastric, lung, colon, breast, liver, pancreatic, ovarian and uterine cancer, as well as rare cancers such as melanoma and sarcoma) can be tested for somatic ...
Manufactured by:Soteria Medical BV based inArnhem, NETHERLANDS
Prostate cancer is the most common cancer, other than non-melanoma skin cancer, and the second leading cause of cancer-related death in men in the United States. Prostate cancer incidence rates rose dramatically in the late 1980s, when screening with the prostate-specific antigen (PSA) test, which received initial U.S. Food and Drug Administration approval in 1986, came into wide use. It is ...